As European markets navigate the complexities of interest rate policies and trade tensions, major indices like Germany’s DAX and Italy’s FTSE MIB have shown resilience with modest gains. In this context, penny stocks—though a somewhat outdated term—remain an intriguing investment area for those seeking growth opportunities at lower price points. These smaller or newer companies can offer significant potential when backed by strong financials, making them worth watching for investors aiming to uncover hidden value in quality stocks.

Name

Share Price

Market Cap

Financial Health Rating

Ariston Holding (BIT:ARIS)

€4.216

€1.46B

★★★★★☆

Lucisano Media Group (BIT:LMG)

€1.11

€16.49M

★★★★☆☆

Maps (BIT:MAPS)

€3.24

€43.03M

★★★★★★

Angler Gaming (NGM:ANGL)

SEK3.60

SEK269.95M

★★★★★★

Angler Gaming (DB:0QM)

€0.37

€224.95M

★★★★★★

Hove (CPSE:HOVE)

DKK4.49

DKK113.52M

★★★★★★

Siili Solutions Oyj (HLSE:SIILI)

€4.85

€39.33M

★★★★★★

Hifab Group (OM:HIFA B)

SEK3.44

SEK209.29M

★★★★★☆

Nurminen Logistics Oyj (HLSE:NLG1V)

€1.04

€83.92M

★★★★★☆

Deceuninck (ENXTBR:DECB)

€2.20

€304.09M

★★★★★★

Click here to see the full list of 270 stocks from our European Penny Stocks screener.

We’ll examine a selection from our screener results.

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Reka Industrial Oyj is a company that manufactures and sells rubber products in Finland and Poland, with a market cap of €25.90 million.

Operations: The company generates €28.82 million in revenue from its rubber segment.

Market Cap: €25.9M

Reka Industrial Oyj, with a market cap of €25.90 million, has shown promising financial stability and growth potential. The company’s price-to-earnings ratio of 16.3x is below the Finnish market average, suggesting good value. Reka’s debt is well-covered by operating cash flow, and it holds more cash than total debt, indicating strong financial health. It reported a net income of €0.942 million for the half-year ending June 2025 compared to a loss previously, highlighting its recent profitability turnaround. However, challenges include a low return on equity and an inexperienced board with an average tenure of just 0.8 years.

HLSE:REKA Financial Position Analysis as at Oct 2025 HLSE:REKA Financial Position Analysis as at Oct 2025

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Navigo Invest AB (publ) is a private equity and venture capital firm that focuses on a range of investment stages including buyouts, early and later stage investments, with a market cap of SEK350.33 million.

Story Continues

Operations: Navigo Invest’s revenue is primarily derived from its segments: Chemgroup (SEK266.55 million), The Geogroup (SEK44.17 million), The Calorimeter (SEK87.65 million), and The Vinga Group (SEK200.88 million).

Market Cap: SEK350.33M

Navigo Invest AB (publ), with a market cap of SEK350.33 million, operates in the private equity and venture capital space but remains unprofitable despite having sufficient cash runway for more than three years due to positive free cash flow. The company’s short-term assets exceed both its long-term and short-term liabilities, indicating solid liquidity management. However, it faces challenges such as a negative return on equity and increasing losses over the past five years. Recent earnings reports show declining revenue from SEK163.29 million to SEK150.81 million year-over-year for Q2 2025, alongside a shift from net income to a net loss of SEK3.57 million.

OM:NAVIGO STAM Debt to Equity History and Analysis as at Oct 2025 OM:NAVIGO STAM Debt to Equity History and Analysis as at Oct 2025

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Onesano S.A. operates in Poland, focusing on research and development in dietetics, animal nutrition, bioremediation, and agrotechnological processes with a market cap of PLN62.19 million.

Operations: The company generates revenue of PLN11.43 billion from its Vitamins & Nutrition Products segment.

Market Cap: PLN62.19M

Onesano S.A., with a market cap of PLN62.19 million, operates in Poland’s research and development sector but remains pre-revenue with limited revenue of PLN11 million from its Vitamins & Nutrition Products segment. Despite being unprofitable, the company has no debt and its short-term assets exceed both short-term and long-term liabilities, reflecting a stable financial position. However, it faces challenges such as a negative return on equity and increased losses over the past five years by 35.3% annually. Recent earnings reported for H1 2025 indicate slight revenue growth to PLN5.3 million but continued net losses of PLN2.12 million compared to prior periods.

WSE:ONO Financial Position Analysis as at Oct 2025 WSE:ONO Financial Position Analysis as at Oct 2025

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HLSE:REKA OM:NAVIGO STAM and WSE:ONO.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com